Boothbay Fund Management’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$184K Sell
35,076
-304,326
-90% -$1.03M ﹤0.01% 1952
2026
Q1
$597K Buy
339,402
+318,213
+1,502% +$690K 0.01% 1247
2025
Q4
$49.8K Sell
21,189
-41,961
-66% -$115K ﹤0.01% 1821
2025
Q3
$193K Buy
+63,150
New +$180K ﹤0.01% 1652
2021
Q2
– Sell
-10,420
Closed -$79K – 1885
2021
Q1
$79K Buy
+10,420
New +$118K ﹤0.01% 1483
2020
Q4
– Sell
-43,770
Closed -$545K – 1252
2020
Q3
$545K Buy
+43,770
New +$484K 0.03% 619

Other funds holding CLOV

Boothbay Fund Management's CLOV Position: Q2 2026 in Review

Boothbay Fund Management reduced its Clover Health Investments (CLOV) stake by 90% in Q2 2026, selling an estimated $1.03M and leaving 35,076 shares worth $184K. The position accounts for ﹤0.01% of the portfolio, ranked #1952.

Boothbay Fund Management first reported a position in CLOV in Q3 2020 and has held it in 6 quarters since. The position peaked at $597K in Q1 2026. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • Boothbay Fund Management held 35,076 shares of Clover Health Investments worth $184K as of Q2 2026.
  • Boothbay Fund Management sold 304,326 Clover Health Investments shares in Q2 2026, an estimated $1.03M.
  • Clover Health Investments made up ﹤0.01% of Boothbay Fund Management's portfolio in Q2 2026, its #1952 holding.
  • Boothbay Fund Management first reported a position in Clover Health Investments in Q3 2020 and has held it in 6 quarters since.
  • Boothbay Fund Management's Clover Health Investments position peaked at $597K in Q1 2026.
  • 227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Boothbay Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.